168 related articles for article (PubMed ID: 6205414)
1. Seasonal variations of human lumbar CSF neurotransmitter metabolite concentrations.
Losonczy MF; Mohs RC; Davis KL
Psychiatry Res; 1984 May; 12(1):79-87. PubMed ID: 6205414
[TBL] [Abstract][Full Text] [Related]
2. Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.
Palmer AM; Sims NR; Bowen DM; Neary D; Palo J; Wikstrom J; Davison AN
J Neurol Neurosurg Psychiatry; 1984 May; 47(5):481-4. PubMed ID: 6204017
[TBL] [Abstract][Full Text] [Related]
3. Significance of decreased lumbar CSF levels of HVA and 5-HIAA in Alzheimer's disease.
Blennow K; Wallin A; Gottfries CG; Lekman A; Karlsson I; Skoog I; Svennerholm L
Neurobiol Aging; 1992; 13(1):107-13. PubMed ID: 1371850
[TBL] [Abstract][Full Text] [Related]
4. CSF levels of neurotransmitters in Alzheimer-type dementia. Effects of ergoloid mesylate.
Seeldrayers P; Messina D; Desmedt D; Dalesio O; Hildebrand J
Acta Neurol Scand; 1985 May; 71(5):411-4. PubMed ID: 2409733
[TBL] [Abstract][Full Text] [Related]
5. No major influence of regular tobacco smoking on cerebrospinal fluid monoamine metabolite concentrations in patients with psychotic disorder and healthy individuals.
Hjärpe J; Söderman E; Andreou D; Sedvall GC; Agartz I; Jönsson EG
Psychiatry Res; 2018 May; 263():30-34. PubMed ID: 29482043
[TBL] [Abstract][Full Text] [Related]
6. Monoamine neurotransmitter interactions in drug-free and neuroleptic-treated schizophrenics.
Hsiao JK; Colison J; Bartko JJ; Doran AR; Konicki PE; Potter WZ; Pickar D
Arch Gen Psychiatry; 1993 Aug; 50(8):606-14. PubMed ID: 7688209
[TBL] [Abstract][Full Text] [Related]
7. Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine: correlations to clinical outcome and HVA, 5-HIAA, and MHPG in CSF.
Nikisch G; Baumann P; Wiedemann G; Kiessling B; Weisser H; Hertel A; Yoshitake T; Kehr J; Mathé AA
J Clin Psychopharmacol; 2010 Oct; 30(5):496-503. PubMed ID: 20814316
[TBL] [Abstract][Full Text] [Related]
8. CSF monoamine metabolite levels in Alzheimer's and Parkinson's disease.
Gibson CJ; Logue M; Growdon JH
Arch Neurol; 1985 May; 42(5):489-92. PubMed ID: 2581531
[TBL] [Abstract][Full Text] [Related]
9. Monoamine metabolites in the CSF of epileptic patients.
Laxer KD; Sourkes TL; Fang TY; Young SN; Gauthier SG; Missala K
Neurology; 1979 Aug; 29(8):1157-61. PubMed ID: 37460
[TBL] [Abstract][Full Text] [Related]
10. Intercorrelations among monoamine metabolite concentrations in human lumbar CSF are not due to a shared acid transport system.
Jibson M; Faull KF; Csernansky JG
Biol Psychiatry; 1990 Oct; 28(7):595-602. PubMed ID: 1699614
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid levels of monoamine metabolites in panic disorder.
Eriksson E; Westberg P; Alling C; Thuresson K; Modigh K
Psychiatry Res; 1991 Mar; 36(3):243-51. PubMed ID: 1712114
[TBL] [Abstract][Full Text] [Related]
12. CSF monoamine metabolites in chronic schizophrenic patients who attempt suicide.
Roy A; Ninan P; Mazonson A; Pickar D; Van Kammen D; Linnoila M; Paul SM
Psychol Med; 1985 May; 15(2):335-40. PubMed ID: 2410941
[TBL] [Abstract][Full Text] [Related]
13. Spinal reflexes and the concentrations of 5-HIAA, MHPG, and HVA in lumbar cereborspinal fluid after spinal lesions in man.
Ashby P; Verrier M; Warsh JJ; Price KS
J Neurol Neurosurg Psychiatry; 1976 Dec; 39(12):1191-200. PubMed ID: 1011029
[TBL] [Abstract][Full Text] [Related]
14. Neuropsychological test performance and CSF levels of monoamine metabolites in healthy volunteers and patients with Alzheimer's dementia.
Nybäck H; Nyman H; Schalling D
Acta Psychiatr Scand; 1987 Dec; 76(6):648-56. PubMed ID: 2450445
[TBL] [Abstract][Full Text] [Related]
15. Aberrant monoamine metabolite levels in CSF and family history of schizophrenia. Their relationships in schizophrenic patients.
Sedvall GC; Wode-Helgodt B
Arch Gen Psychiatry; 1980 Oct; 37(10):1113-6. PubMed ID: 6158928
[TBL] [Abstract][Full Text] [Related]
16. CSF neurochemical study of tardive dyskinesia.
Lu RB; Ko HC; Lin WL; Lin YT; Ho SL
Biol Psychiatry; 1989 Mar; 25(6):717-24. PubMed ID: 2466490
[TBL] [Abstract][Full Text] [Related]
17. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
Scheinin M
Med Biol; 1985; 63(1):1-17. PubMed ID: 2582215
[TBL] [Abstract][Full Text] [Related]
18. Increased concentrations of the monoamine metabolites homovanillic acid and 5-hydroxyindoleacetic acid in lumbar and central CSF and of 3-methoxy-4-hydroxyphenylglycol in lumbar CSF after subarachnoid haemorrhage.
von Holst H; Lindquist C; Sedvall G
Acta Neurochir (Wien); 1985; 77(3-4):146-51. PubMed ID: 2416192
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid neurotransmitter metabolites in neurologically normal infants and children.
Langlais PJ; Walsh FX; Bird ED; Levy HL
Pediatrics; 1985 Mar; 75(3):580-6. PubMed ID: 2579365
[TBL] [Abstract][Full Text] [Related]
20. CSF monoamine metabolites and somatostatin in Alzheimer's disease and major depression.
Molchan SE; Lawlor BA; Hill JL; Martinez RA; Davis CL; Mellow AM; Rubinow DR; Sunderland T
Biol Psychiatry; 1991 Jun; 29(11):1110-8. PubMed ID: 1714776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
